Efficacy of chemotherapy after progression with nivolumab in squamous cell carcinoma of the head and neck
{{output}}
Nivolumab, a programmed death-1 (PD-1) inhibitor, has shown promising results against squamous cell carcinoma of the head and neck (SCCHN) in cases of recurrence or in a metastatic setting after platinum-based therapy. However, treatment alternatives for patie... ...
